cyclophosphamide + doxorubicin + gemcitabine + etoposide

This is a **four-drug chemotherapy combination** consisting of cyclophosphamide, doxorubicin, gemcitabine, and etoposide, all of which are cytotoxic agents commonly used in the treatment of various cancers. Cyclophosphamide is an alkylating agent causing DNA crosslinking; doxorubicin is an anthracycline antibiotic that intercalates DNA and inhibits topoisomerase II; gemcitabine is a nucleoside analog inhibiting DNA synthesis; and etoposide is a topoisomerase II inhibitor causing DNA strand breaks. This particular combination does not correspond to a widely recognized or named regimen in current clinical oncology practice or reference regimens. Each component is FDA-approved for cancer treatment, but this specific 4-drug mix may be used in certain investigational or individualized protocols.